412 results on '"Wee, Joseph"'
Search Results
2. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma
3. Chemotherapy for Locoregionally Advanced NPC
4. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
5. Self‐Degrading Molecular Organogels: Self‐Assembled Gels Programmed to Spontaneously Liquefy after a Set Time
6. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
7. Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma
8. 18F‐FMISO PET‐guided dose escalation with multifield optimization intensity‐modulated proton therapy in nasopharyngeal carcinoma.
9. Genomic analyses inform on migration events during the peopling of Eurasia
10. The Simons Genome Diversity Project: 300 genomes from 142 diverse populations
11. Global diversity, population stratification, and selection of human copy-number variation.
12. Global diversity, population stratification, and selection of human copy-number variation
13. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer – A prospective cohort analysis
14. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors
15. The Americanization of a Filipina U.S. Navy Wife
16. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines
17. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
18. P206 / #618 - AN INITIAL EXPERIENCE WITH PROTON PLAN ADAPTATION FOR HEAD AND NECK CANCERS
19. O060 / #409 - PROSPECTIVE EVALUATION OF ACUTE TOXICITY DURING IMPT FOR HEAD AND NECK MALIGNANCIES IN NATIONAL CANCER CENTRE SINGAPORE (NCCS)
20. The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients – a national cancer centre experience
21. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
22. 18F‐FMISO PET‐guided dose escalation with multifield optimization intensity‐modulated proton therapy in nasopharyngeal carcinoma
23. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials
24. Nasopharyngeal carcinoma
25. Supplementary Materials from Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
26. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
27. Concurrent Chemotherapy-Enhanced Radiation: Trials and Conclusions
28. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
29. Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC
30. Multimodality Management of Nasopharyngeal Carcinoma
31. Commentary on “Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial”
32. Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward
33. Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients
34. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
35. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
36. HUMAN GENOMICS: Global diversity, population stratification, and selection of human copy-number variation
37. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis
38. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
39. Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index
40. The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients
41. Dr. PA Shah Oration 2022.
42. Nasopharyngeal Carcinoma: Management Strategies
43. Can external and subjective information ever be used to reduce the size of randomised controlled trials?
44. Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma
45. Abstract 2258: Germline variants associated with poorer disease prognosis in nasopharyngeal carcinoma
46. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
47. EBV and NPC carcinogenesis—an alternative viewpoint
48. Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
49. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma.
50. Novel Surfactant for Spacer-Less Cementing Compatible with Non Aqueous Fluids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.